Skip to main content

 home page
 about mesothelioma
 your diagnosis
 treatment of cancer
 caregiving
 health and wellness
 coping with cancer
 finance and planning
 Support and Links
 contact us

 Mesothelioma Aid logo 800-998-9729  
 

Data Supports Further Investigation of Mesothelioma Virotherapy

Oncolytics Biotech presented data that indicates malignant mesothelioma cells are sensitive to certain viruses. Their presentation titled “Combination Immunotherapy and Oncolytics Virotherapy for the Treatment of Malignant Mesothelioma” discussed in vitro data showing mesothelioma cells could be suitable targets for reoviruses which could then attack and compromise them.

The company currently has 7 ongoing phase I and phase II trials though none are currently for mesothelioma patients. Reoviruses, which the company is investigating, are generally gastrointestinal infections with the most common form being the rotavirus.

The goal of virotherapy is to isolate and reprogram viruses to only attack cancerous cells. It is still a relatively undeveloped field within cancer research but progress is being made.

Leave a Reply

You must be logged in to post a comment.


About Mesothelioma / Mesothelioma Diagnosis / Coping / Staying Healthy / Mesothelioma Blog
Financial Planning / Caregiver's Guide / Patient Support / Contact Us /
Disclaimer and Sponsorship
 





Mesothelioma Aid is a website devoted to life issues for mesothelioma patients and their families, and is sponsored by Jonathan David* of The David Law Firm. The David Law Firm is located in The Woodlands, Texas (Greater Houston Area) and can be reached toll free at 1-800-998-9729 for more information on mesothelioma. Jonathan David is not a medical doctor. The information on these pages is for the education of mesothelioma patients and their families regarding potential medical and legal options. Patients are advised to consult with a medical doctor.

*  Licensed by the Supreme Court  of Texas.

Copyright © The David Law Firm